TY - JOUR AU - Schulz, Dominik AU - Algül, Hana PY - 2019 TI - Chemotherapy of pancreatic cancer in patients with poor performance JF - Chinese Clinical Oncology; Vol 8, Supplement 1 (October 22, 2019): Chinese Clinical Oncology Y2 - 2019 KW - N2 - Pancreatic cancer is the seventh most leading cause of all cancer related deaths, accounting for 4.5% of these (1,2). Less than 20 % of the patients who are diagnosed with pancreatic ductal adenocarcinoma present with a nonmetastatic localized disease and surgery is a potential curative option (3). Another third of the patients present with locally advanced nonmetastatic cancer and may undergo neoadjuvant chemotherapy with or without radiation followed by exploration and resection as a possible curative treatment. In most of the cases however, patients are diagnosed with a metastatic disease and chemotherapy is the only viable option to increase overall survival and improve quality of life by relieving symptoms. UR - https://cco.amegroups.org/article/view/28285